NO20014341D0 - Dissolution of polyunsaturated fatty acids and derivatives thereof by formation of <gamma> cyclodextrin inclusion compositions and their use in pharmaceutical, cosmetic or food compositions - Google Patents

Dissolution of polyunsaturated fatty acids and derivatives thereof by formation of <gamma> cyclodextrin inclusion compositions and their use in pharmaceutical, cosmetic or food compositions

Info

Publication number
NO20014341D0
NO20014341D0 NO20014341A NO20014341A NO20014341D0 NO 20014341 D0 NO20014341 D0 NO 20014341D0 NO 20014341 A NO20014341 A NO 20014341A NO 20014341 A NO20014341 A NO 20014341A NO 20014341 D0 NO20014341 D0 NO 20014341D0
Authority
NO
Norway
Prior art keywords
compositions
cosmetic
dissolution
gamma
pharmaceutical
Prior art date
Application number
NO20014341A
Other languages
Norwegian (no)
Other versions
NO20014341L (en
Inventor
Florence Pilard Djedaini
Bruno Perly
Jean-Pierre Dalbiez
Quitterie Michon
Beatrice Rousseau
Pascale Barrier
Original Assignee
Sea Oil
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sea Oil filed Critical Sea Oil
Publication of NO20014341L publication Critical patent/NO20014341L/en
Publication of NO20014341D0 publication Critical patent/NO20014341D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/925—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of animal origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Dermatology (AREA)
  • Food Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mycology (AREA)
NO20014341A 1999-03-09 2001-09-06 Dissolution of polyunsaturated fatty acids and derivatives thereof by formation of <gamma> cyclodextrin inclusion compositions and their use in pharmaceutical, cosmetic or food compositions NO20014341D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9902881A FR2790758A1 (en) 1999-03-09 1999-03-09 SOLUBILIZATION OF POLYUNSATURATED FATTY ACIDS AND DERIVATIVES THEREOF BY FORMATION OF INCLUSION COMPLEXES WITH A CYCLODEXTRIN AND THEIR USE IN PHARMACEUTICAL, COSMETIC OR FOOD COMPOSITIONS
PCT/FR2000/000560 WO2000053637A1 (en) 1999-03-09 2000-03-07 INCLUSION COMPLEXES OF POLYUNSATURATED FATTY ACIDS AND THEIR DERIVATIVES WITH η-CYCLODEXTRIN

Publications (2)

Publication Number Publication Date
NO20014341L NO20014341L (en) 2001-09-06
NO20014341D0 true NO20014341D0 (en) 2001-09-06

Family

ID=9542970

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014341A NO20014341D0 (en) 1999-03-09 2001-09-06 Dissolution of polyunsaturated fatty acids and derivatives thereof by formation of <gamma> cyclodextrin inclusion compositions and their use in pharmaceutical, cosmetic or food compositions

Country Status (6)

Country Link
EP (1) EP1165620A1 (en)
JP (1) JP2002539138A (en)
CA (1) CA2366719A1 (en)
FR (1) FR2790758A1 (en)
NO (1) NO20014341D0 (en)
WO (1) WO2000053637A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10253042A1 (en) 2002-11-14 2004-06-03 Wacker-Chemie Gmbh Cosmetic preparation containing a complex of cyclodextrin and vitamin F.
ES2209658B1 (en) * 2002-12-05 2005-10-01 Proyecto Empresarial Brudy, S.L. USE OF DOCOSAHEXAENOIC ACID AS AN ACTIVE PRINCIPLE FOR THE TREATMENT OF LIPODYSTROPHY.
FR2850040B1 (en) * 2003-01-20 2005-03-11 Centre Nat Rech Scient SYSTEMS FOR MICROENCAPSULATION AND THEIR APPLICATIONS
US7105195B2 (en) 2003-07-25 2006-09-12 General Mills, Inc. Reduced trans fat product
US20040180125A1 (en) * 2003-03-11 2004-09-16 Plank David W. Cyclodextrin-containing compositions and methods
US7335386B2 (en) 2003-07-30 2008-02-26 Gerneral Mills, Inc. Method for preventing acrylamide formation in food products and food intermediates
EP1637134A4 (en) * 2003-06-20 2010-01-27 Mochida Pharm Co Ltd Composition for prevention/treatment for varicose veins
EP2049083A2 (en) * 2006-12-27 2009-04-22 Cargill, Incorporated Stabilisation by preparing cyclodextrin inclusion complexes
FR2915901A1 (en) * 2007-05-07 2008-11-14 In Cyclo Soc Par Actions Simpl HOMOGENEOUS AND STABLE COMPOSITION, RICH IN OLEAGINOUS SUBSTANCES BASED ON A MILK PRODUCT, PROCESS FOR PREPARING SAME AND USES THEREOF.
GB0710439D0 (en) * 2007-05-31 2007-07-11 Uni I Oslo Oral dosage form
GB0808479D0 (en) * 2008-05-09 2008-06-18 Uni I Oslo Topical compositions
FR3048177B1 (en) * 2016-02-25 2020-10-30 Fabre Pierre Dermo Cosmetique BIPHASE COSMETIC COMPOSITION AND ITS USE BY TOPICAL APPLICATION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5813541A (en) * 1981-07-16 1983-01-26 Kureha Chem Ind Co Ltd Cyclodextrin clathrate compound of eicosapentaenoic acid or docosahexaenoic acid
JPS5941395A (en) * 1982-09-01 1984-03-07 マルハ株式会社 Stabilization of fish oils
JPS6034156A (en) * 1983-08-08 1985-02-21 Hayashibara Biochem Lab Inc Eicosapentaenoic acid clathrate compound and food and drink containing the same
IT1243192B (en) * 1990-08-09 1994-05-24 Staroil Ltd LONG CHAIN POLYUNSATURATED FATTY ACIDS AND THEIR DERIVATIVES, WITH CYCLODESTRINE
JPH0725816A (en) * 1993-07-08 1995-01-27 Yoshihisa Matsuda Polyenoic acid clathrate

Also Published As

Publication number Publication date
CA2366719A1 (en) 2000-09-14
JP2002539138A (en) 2002-11-19
NO20014341L (en) 2001-09-06
EP1165620A1 (en) 2002-01-02
FR2790758A1 (en) 2000-09-15
WO2000053637A1 (en) 2000-09-14

Similar Documents

Publication Publication Date Title
HUP0101653A3 (en) Fatty acid derivatives of bile acids and bile acid derivatives and pharmaceutical compositions thereof
NO20014341D0 (en) Dissolution of polyunsaturated fatty acids and derivatives thereof by formation of &lt;gamma&gt; cyclodextrin inclusion compositions and their use in pharmaceutical, cosmetic or food compositions
HUP0200895A3 (en) Benzimidazole derivatives of alpha-substituted carboxylic acids, pharmaceutical compositions containing them and their use
MA26935A1 (en) PHARMACEUTICAL COMPOSITIONS OF CHOLESTERYL ESTER TRANSFER PROTEIN INHIBITORS
HUP0400056A2 (en) Thiazole or oxazole derivatives which are useful in the treatment of cardiovascular diseases and pharmaceutical compositions containing them
PL352282A1 (en) Derivatives of thiazoles and pharmaceutical compositions containing these derivatives
NO20015782L (en) Dietary composition or pharmaceutical composition for use in the prevention or treatment of hyperoxaluria
IL191486A0 (en) Piperidine derivatives, process for their preparation, pharmaceutical compositions containing them and use thereof in the preparation of medicaments for the treatment of tachykinis mediated conditions
DE60100186D1 (en) ORAL PHARMACEUTICAL FORMULATIONS OF BENZIMIDAZOLE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
IL147556A0 (en) Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents
HUP0100819A3 (en) Aminophenoxyacetic acid derivatives as neuroprotectants and pharmaceutical compositions containing them
DE60215851D1 (en) N-ADAMANTYLMETHYL DERIVATIVES AND INTERMEDIATE PRODUCTS AS PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF
WO2003013439A3 (en) Anti-irritants
MA27392A1 (en) NOVEL AMINOINDAZOLES DERIVATIVES AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
NO20031622D0 (en) Medical compositions that rapidly disintegrate in the oral cavity and process for the preparation of the same
EE200200628A (en) Process for the preparation of dihydroxy esters and their derivatives
IL150849A0 (en) Piperzine and piperidine derivatives and pharmaceutical compositions containg the same
AU5309400A (en) Methods and compositions for the treatment of neuroleptic and related disorders using sertindole derivatives
HUP0400801A3 (en) Pharmaceutical compositions containing bile acid or bile salt fatty acid conjugates and their use
AU2614200A (en) Composition for stabilizing and potentiating the action of anti-angiogenic substances by polyunsaturated fatty acids
IL151912A0 (en) Pyrolidine derivatives, their preparation and pharmaceutical compositions containing them
AU2003234545A8 (en) Pharmaceutical compositions and methods of using c-21 modified epothilone derivatives
HUP0203187A3 (en) Isoxazole derivatives to be used as phosphodiesterase vii inhibitors and pharmaceutical compositions containing them
NO20014540D0 (en) Use of inulin in meat products
FR2822700B1 (en) NEW DENTAL HYGIENE PRODUCT IN THE FORM OF NUTRICAMENT UNIDOSE GELIFYING EXTENDED ACTION AND NEW COMPOSITIONS ADAPTED IN COMPRESS OR SEMISOLID GEL